SEC Comment Letter 0000000000-24-010974 to Glucotrack, Inc. (GCTK)
Glucotrack, Inc.
Date: Sept. 27, 2024 · CIK: 0001506983 · Accession: 0000000000-24-010974
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282297
Letter
September 27, 2024 Paul Goode Chief Executive Officer Glucotrack, Inc. 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070 Re:Glucotrack, Inc. Registration Statement on Form S-3 Filed September 23, 2024 File No. 333-282297 Dear Paul Goode: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Howard Hirsch, Esq.
Show Raw Text
September 27, 2024
Paul Goode
Chief Executive Officer
Glucotrack, Inc.
301 Rte. 17 North, Ste. 800,
Rutherford, NJ 07070
Re:Glucotrack, Inc.
Registration Statement on Form S-3
Filed September 23, 2024
File No. 333-282297
Dear Paul Goode:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Howard Hirsch, Esq.